Center-Authored Papers

Filters: Author is Chen, Y Ann  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
2011
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
2013
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
3' Untranslated Regions
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
April 2013
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
Center-Authored Paper
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Disease-Free Survival
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Early Detection of Cancer
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Female
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Genes, BRCA1
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Genetic Predisposition to Disease
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Genotype
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Humans
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
MICRORNAS
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Neoplasm Invasiveness
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Neoplasms, Glandular and Epithelial
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Ovarian Neoplasms
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Polymorphism, Single Nucleotide
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Proto-Oncogene Proteins
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Public Health Sciences Division
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin H-Y, Chen AY, Tsai Y-Y, Qu X et al..  2013.  Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.. Nature communications. 4:1627. Abstract
ras Proteins
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract
RISK
Pharoah PDP, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS et al..  2011.  The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.. Clinical cancer research : an official journal of the American Association for Cancer Research. 17(11):3742-50. Abstract